VoiceS: voice quality after transoral CO2 laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer —a randomized phase III trial
DiscussionTo our knowledge, VoiceS is the first randomized phase III trial comparing SVCI with TLM. Results of this study may lead to improved decision-making in the treatment of ESGC.Trial registrationClinicalTrials.gov NCT04057209. Registered on 15 August 2019. Cantonal Ethics Committee KEK-BE 2019-01506 (Source: Trials)
Source: Trials - October 27, 2022 Category: Research Source Type: clinical trials

Vitamin-D Receptor in Laryngeal Squamous Cell Carcinoma
Condition:   Vitamin-D Receptor - Laryngeal Carcinoma Intervention:   Sponsor:   Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2022 Category: Research Source Type: clinical trials